What's Next for Valeant Pharmaceuticals?

Feb 29, 2016, 11:11 PM

Headliner
Share
Subscribe

After a postponed earnings call, can the return of chief executive Michael Pearson help Valeant Pharmaceuticals find its way out of a cloud of uncertainty?

Share
Subscribe
Next
Are Financial Trends Shifting for the Wealthy?
Top episodes
How Printing Fake Money Helped People Manage Their Cash
by WSJ Your Money Matters
Where to Put Your Cash if the Fed Lowers Interest Rates
by WSJ Your Money Matters
How to Get Out of Debt
by WSJ Your Money Matters